GCM
AMGN icon

Gallacher Capital Management’s Amgen AMGN Stock Holding History

Gallacher Capital Management’s Portfolio AMGN Stock Details AMGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$288K Sell
797
-210
-21% -$71.9K 0.16% 199
2026
Q1 		$354K Sell
1,007
-41
-4% -$14.6K 0.14% 204
2025
Q4 		$343K Hold
1,048
– – 0.13% 210
2025
Q3 		$296K Sell
1,048
-67
-6% -$19.4K 0.12% 238
2025
Q2 		$311K Hold
1,115
– – 0.14% 204
2025
Q1 		$347K Hold
1,115
– – 0.17% 175
2024
Q4 		$291K Buy
1,115
+123
+12% +$36.5K 0.14% 198
2024
Q3 		$320K Sell
992
-6
-0.6% -$1.96K 0.15% 190
2024
Q2 		$312K Sell
998
-8
-0.8% -$2.35K 0.16% 175
2024
Q1 		$286K Buy
1,006
+54
+6% +$15.8K 0.15% 191
2023
Q4 		$274K Sell
952
-80
-8% -$21.8K 0.15% 180
2023
Q3 		$277K Buy
1,032
+104
+11% +$26K 0.17% 160
2023
Q2 		$206K Sell
928
-518
-36% -$120K 0.12% 228
2023
Q1 		$350K Buy
1,446
+537
+59% +$132K 0.21% 128
2022
Q4 		$239K Buy
+909
New +$244K 0.14% 184

Other funds holding AMGN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Gallacher Capital Management's AMGN Position: Q2 2026 in Review

Gallacher Capital Management reduced its Amgen (AMGN) stake by 21% in Q2 2026, selling an estimated $71.9K and leaving 797 shares worth $288K. The position accounts for 0.16% of the portfolio, ranked #199.

Gallacher Capital Management first reported a position in AMGN in Q4 2022 and has held it in 15 quarters since. The position peaked at $354K in Q1 2026. 3,139 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • Gallacher Capital Management held 797 shares of Amgen worth $288K as of Q2 2026.
  • Gallacher Capital Management sold 210 Amgen shares in Q2 2026, an estimated $71.9K.
  • Amgen made up 0.16% of Gallacher Capital Management's portfolio in Q2 2026, its #199 holding.
  • Gallacher Capital Management first reported a position in Amgen in Q4 2022 and has held it in 15 quarters since.
  • Gallacher Capital Management's Amgen position peaked at $354K in Q1 2026.
  • 3,139 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Gallacher Capital Management's 13F filing for Q2 2026, filed 17 Jul 2026.